PharmaResearch’s restructuring plan, echoing Google’s 2015 move, sparked a 17% share price drop as investors questioned dual listing and shareholder motives.
#YonhapInfomax #PharmaResearch #Google #HoldingCompany #DualListing #SharePriceDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=69187

GC Genome's planned dual listing has sparked concerns over conflicts of interest between parent and subsidiary shareholders due to high intra-group transactions, with experts warning of potential negative impacts on share price and the Korea Discount.
#YonhapInfomax #GCGenome #DualListing #InternalTransactions #KoreaDiscount #ShareholderConflict #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65339

Dongwon Group to delist Dongwon F&B, maintaining 78.9% ownership post-exchange, as part of strategy to enhance global food business and shareholder value
#YonhapInfomax #DongwonGroup #StockExchange #DualListing #ShareholderValue #CorporateGovernance #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=58857

LS Group addresses dual listing concerns, emphasizing strategic growth and shareholder value preservation in upcoming subsidiary IPOs
#YonhapInfomax #LSGroup #DualListing #IPO #ShareholderValue #CorporateStrategy #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=55892